Heart Test Laboratories (HSCS) Stock Forecast, Price Target & Predictions
HSCS Stock Forecast
Heart Test Laboratories stock forecast is as follows: an average price target of $3.00 (represents a 9.89% upside from HSCS’s last price of $2.73) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
HSCS Price Target
The average price target for Heart Test Laboratories (HSCS) is $3.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $3.00. This represents a potential 9.89% upside from HSCS's last price of $2.73.
HSCS Analyst Ratings
According to 1 Wall Street analysts, Heart Test Laboratories's rating consensus is 'Buy'. The analyst rating breakdown for HSCS stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Heart Test Laboratories Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 19, 2022 | - | Maxim Group | $3.00 | $0.90 | 233.33% | 9.89% |
The latest Heart Test Laboratories stock forecast, released on Dec 19, 2022 by Maxim Group company, set a price target of $3.00, which represents a 233.33% increase from the stock price at the time of the forecast ($0.90), and a 9.89% increase from HSCS last price ($2.73).
Heart Test Laboratories Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $2.73 | $2.73 | $2.73 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Heart Test Laboratories stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Heart Test Laboratories's last price of $2.73. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 19, 2022 | Maxim Group | Buy | Buy | Hold |
Heart Test Laboratories's last stock rating was published by Maxim Group on Dec 19, 2022. The company gave HSCS a "Buy" rating, the same as its previous rate.
Heart Test Laboratories Financial Forecast
Heart Test Laboratories Revenue Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $1.95K | $3.20K |
| Avg Forecast | $1.00M | $100.00K | $350.00K | $200.00K | $50.00K | $550.00K | $400.00K | $200.00K | $50.00K | $1.00K | $3.00K |
| High Forecast | $1.00M | $100.00K | $350.00K | $200.00K | $50.00K | $575.00K | $400.00K | $200.00K | $50.00K | $1.00K | $3.00K |
| Low Forecast | $1.00M | $100.00K | $350.00K | $200.00K | $50.00K | $525.00K | $400.00K | $200.00K | $50.00K | $1.00K | $3.00K |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.95% | 1.07% |
Heart Test Laboratories's average Quarter revenue forecast for May 24 based on 1 analysts is $50.00K, with a low forecast of $50.00K, and a high forecast of $50.00K. HSCS's average Quarter revenue forecast represents a 2464.10% increase compared to the company's last Quarter revenue of $1.95K (Jan 23).
Heart Test Laboratories EBITDA Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | $-1.30M | $-1.42M |
| Avg Forecast | $-1.00M | $-100.00K | $-350.00K | $-200.00K | $-50.00K | $-550.00K | $-400.00K | $-200.00K | $-50.00K | $-1.00K | $-3.00K |
| High Forecast | $-1.00M | $-100.00K | $-350.00K | $-200.00K | $-50.00K | $-525.00K | $-400.00K | $-200.00K | $-50.00K | $-1.00K | $-3.00K |
| Low Forecast | $-1.00M | $-100.00K | $-350.00K | $-200.00K | $-50.00K | $-575.00K | $-400.00K | $-200.00K | $-50.00K | $-1.00K | $-3.00K |
| Surprise % | - | - | - | - | - | - | - | - | - | 1302.44% | 474.43% |
undefined analysts predict HSCS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Heart Test Laboratories's previous annual EBITDA (undefined) of $NaN.
Heart Test Laboratories Net Income Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | $-1.37M | $-1.72M |
| Avg Forecast | $-952.74K | $-1.19M | $-1.22M | $-1.35M | $-1.45M | $-1.68M | $-1.82M | $-1.79M | $-2.72M | $-12.44M | $-21.78M |
| High Forecast | $-952.74K | $-1.19M | $-1.22M | $-1.35M | $-1.45M | $-1.68M | $-1.82M | $-1.79M | $-2.72M | $-12.44M | $-21.78M |
| Low Forecast | $-952.74K | $-1.19M | $-1.22M | $-1.35M | $-1.45M | $-1.68M | $-1.82M | $-1.79M | $-2.72M | $-12.44M | $-21.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.11% | 0.08% |
Heart Test Laboratories's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. HSCS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Heart Test Laboratories SG&A Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | $667.24K | $997.06K |
| Avg Forecast | $215.19M | $21.52M | $75.32M | $43.04M | $10.76M | $118.35M | $86.08M | $43.04M | $10.76M | $215.19K | $645.57K |
| High Forecast | $215.19M | $21.52M | $75.32M | $43.04M | $10.76M | $123.73M | $86.08M | $43.04M | $10.76M | $215.19K | $645.57K |
| Low Forecast | $215.19M | $21.52M | $75.32M | $43.04M | $10.76M | $112.97M | $86.08M | $43.04M | $10.76M | $215.19K | $645.57K |
| Surprise % | - | - | - | - | - | - | - | - | - | 3.10% | 1.54% |
Heart Test Laboratories's average Quarter SG&A projection for May 24 is $10.76M, based on 1 Wall Street analysts, with a range of $10.76M to $10.76M. The forecast indicates a 1512.55% rise compared to HSCS last annual SG&A of $667.24K (Jan 23).
Heart Test Laboratories EPS Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.17 | $-0.30 |
| Avg Forecast | $-1.23 | $-1.53 | $-1.57 | $-1.74 | $-1.87 | $-2.16 | $-2.33 | $-2.31 | $-3.50 | $-16.00 | $-28.00 |
| High Forecast | $-1.23 | $-1.53 | $-1.57 | $-1.74 | $-1.87 | $-2.16 | $-2.33 | $-2.31 | $-3.50 | $-16.00 | $-28.00 |
| Low Forecast | $-1.23 | $-1.53 | $-1.57 | $-1.74 | $-1.87 | $-2.16 | $-2.33 | $-2.31 | $-3.50 | $-16.00 | $-28.00 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.01% | 0.01% |
According to undefined Wall Street analysts, Heart Test Laboratories's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to HSCS previous annual EPS of $NaN (undefined).
HSCS Forecast FAQ
Is Heart Test Laboratories a good buy?
Yes, according to 1 Wall Street analysts, Heart Test Laboratories (HSCS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of HSCS's total ratings.
What is HSCS's price target?
Heart Test Laboratories (HSCS) average price target is $3 with a range of $3 to $3, implying a 9.89% from its last price of $2.73. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Heart Test Laboratories stock go up soon?
According to Wall Street analysts' prediction for HSCS stock, the company can go up by 9.89% (from the last price of $2.73 to the average price target of $3), up by 9.89% based on the highest stock price target, and up by 9.89% based on the lowest stock price target.
Can Heart Test Laboratories stock reach $4?
HSCS's average twelve months analyst stock price target of $3 does not support the claim that Heart Test Laboratories can reach $4 in the near future.
Did the HSCS's actual financial results beat the analysts' financial forecasts?
In terms of the last quarterly report (Jan 2023), Heart Test Laboratories's revenue was $1.95K, beating the average analysts' forecast of $1K by 95.00%. The company's EBITDA was $-1.302M, beating the average prediction of $-1K by 130144.50%. Heart Test Laboratories's net income was $-1.375M, missing the average estimation of $-12.444M by -88.95%. The company's SG&A was $667.24K, beating the average forecast of $215.19K by 210.07%. Lastly, the company's EPS was $-0.17, missing the average prediction of $-16 by -98.94%